Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Gilead sciences, inc. crawled time : 12:15 save search
Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
AADI | $1.835 1.94% 1.91% 140K
|
Manufacturing
|
| O: -4.13%
H: 0.0%
C: -16.65%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
financial results results
Jounce Therapeutics Progresses INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and Pimivalimab (PD-1 Inhibitor) Combination Therapy in Patients with Advanced Solid Tumors
Published: 2021-10-07 (Crawled : 12:15) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 1.32%
H: 2.21%
C: 1.3%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.03%
H: 1.21%
C: 0.95%
solid tumors therapy pimivalimab pd-1 inhibitor
Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors
Published: 2021-09-15 (Crawled : 12:15) - globenewswire.com
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -0.97%
H: 0.82%
C: 0.08%
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 0.97%
H: 6.98%
C: 6.16%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.18%
H: 2.7%
C: 1.67%
therapeutics
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
AVTE M | $21.86 1.2% 1.19% 220K
|
Professional, Scientific, and T...
|
| O: -8.86%
H: 4.83%
C: 3.51%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.54%
H: 1.53%
C: 1.41%
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: -3.31%
H: 2.05%
C: -1.37%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.56%
H: 0.81%
C: 0.62%
financial results results therapeutics
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
Published: 2021-07-19 (Crawled : 12:15) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.68%
H: 0.41%
C: -0.31%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.2%
H: 0.67%
C: -0.55%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 1.3%
H: 8.47%
C: 6.42%
therapy
Gilead to Present New Data at IAS 2021 Demonstrating the Company’s Commitment to Advancing Innovation in HIV Research
Published: 2021-07-12 (Crawled : 12:15) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.93%
H: 1.22%
C: -0.23%
research hiv
Jounce Therapeutics Provides Update on INNATE Study and Discovery Pipeline Expansion, and Provides a Portfolio Update at 2021 R&D Day
Published: 2021-06-23 (Crawled : 12:15) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 0.67%
H: 2.13%
C: -0.53%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.24%
H: 0.06%
C: -0.83%
expansion
HOOKIPA to present Phase 1 safety, tolerability and preliminary anti-tumor activity data on HB-201 and HB-202 for the treatment of advanced HPV16+ cancers at ASCO
Published: 2021-05-20 (Crawled : 12:15) - biospace.com/
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: -2.84%
H: 0.54%
C: -9.78%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.23%
H: 1.92%
C: 1.0%
treatment phase 1 cancer phase 3 phase 2
Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors
Published: 2021-05-05 (Crawled : 12:15) - biospace.com/
WFC | $60.35 2.74% -0.13% 34M
|
Finance
|
| O: 0.42%
H: 0.59%
C: 0.02%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.24%
H: 2.61%
C: 2.21%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.22%
H: 0.91%
C: 0.6%
PCVX | $60.82 0.33% 0.33% 1.3M
|
Health Technology
|
| O: 3.85%
H: 1.81%
C: -0.7%
MTCR | $0.5814 -5.14% 84K
|
Health Technology
|
| O: 0.82%
H: 0.82%
C: -2.45%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.15%
H: 1.92%
C: 1.17%
bioscience
Jounce Therapeutics to Present Trial in Progress Posters on the Phase 1 INNATE and the Phase 2 SELECT Clinical Trials at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
Published: 2021-04-28 (Crawled : 12:15) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: -0.3%
H: 0.3%
C: -3.8%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.03%
H: 0.02%
C: -0.39%
phase 2 clinical trials phase 1 trial phase 3
Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer
Published: 2021-04-19 (Crawled : 12:15) - globenewswire.com
TARA | $2.62 -4.73% -4.96% 210K
|
Health Technology
|
| O: -1.26%
H: 2.11%
C: -2.05%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.25%
H: 0.45%
C: -1.12%
HOOKIPA Pharma to Present at Kempen Life Science Conference
Published: 2021-04-14 (Crawled : 12:15) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: 0.08%
H: 2.72%
C: 1.2%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.12%
H: 1.85%
C: 0.51%
life science conference presentation pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.